Literature DB >> 6183191

T-cell-dependent polyclonal activation by soluble mycobacterial extracts of B cells in peripheral blood mononuclear cell populations from leprosy patients and normal donors.

B Fleming, G A Rook.   

Abstract

Soluble extracts of ultrasonically disrupted mycobacteria (including Mycobacterium leprae) cause strong T-cell-dependent, Cyclosporin A-sensitive, polyclonal B-cell activation, in human peripheral blood mononuclear cell preparations. It is not enhanced by cortisol. Cells from cases of lepromatous leprosy show no polyclonal B-cell activation in the presence of extracts of M. leprae, although they respond normally to other mycobacterial species. The polyclonal B-cell activation response to the M. leprae extract, of a small group of normal leprosy contacts, was reduced relative to that of non-contacts.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183191      PMCID: PMC1555566     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Does nonspecific T-lymphocyte stimulation of B lymphocytes occur during reversal reaction in borderline leprosy?

Authors:  R Barnetson; A Barnetson; J M Pearson; G Kronvall
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

2.  PPD-induced immunoglobulin production in human peripheral blood lymphocytes. I. Necessary conditions for inducing the response.

Authors:  S I Nishikawa; T Hirata; T Nagai; M Mayumi; T Izumi
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

3.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

4.  Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte.

Authors:  A G Bird; L Hammarström; C I Smith; S Britton
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

5.  Mitogenic activation of human lymphocytes: a protein A plaque assay evaluation of polyclonal B-cell activators.

Authors:  L Hammarström; A G Bird; C I Smith
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

6.  An inexpensive, portable, battery-operated photometer for the reading of ELISA tests in microtitration plates.

Authors:  G A Rook; C H Cameron
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

7.  Antibody production and DNA synthesis of human lymphocyte subpopulations induced by PPD tuberculin.

Authors:  O Ringdén; B Rynnel-Dagöö; T Kunori; A Freijd; E Möller
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

8.  Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients.

Authors:  V Mehra; L H Mason; W Rothman; E Reinherz; S F Schlossman; B R Bloom
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

9.  The specificity of T-cell helper factor in man.

Authors:  R S Geha; F Mudawwar; E Schneeberger
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

10.  Induction of polyclonal antibody synthesis by human allogeneic and autologous helper factors.

Authors:  N Chiorazzi; S M Fu; H G Kunkel
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  3 in total

1.  Trypanosoma cruzi mitochondrial malate dehydrogenase triggers polyclonal B-cell activation.

Authors:  C L Montes; E I Zuñiga; J Vazquez; C Arce; A Gruppi
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  HLA-DR-associated isotype-specific regulation of antibody levels to mycobacteria in rheumatoid arthritis.

Authors:  G M Bahr; G A Rook; A Shahin; J L Stanford; M I Sattar; K Behbehani
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

3.  Specificity of antibodies secreted by hybridomas generated from activated B cells in the mesenteric lymph nodes of patients with inflammatory bowel disease.

Authors:  L P Chao; J Steele; C Rodrigues; J Lennard-Jones; J L Stanford; C Spiliadis; G A Rook
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.